Related Experiment Video
Updated: Jun 3, 2026
10:21
Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Quantitative chemogenomics: machine-learning models of protein-ligand interaction.
Claes R Andersson1, Mats G Gustafsson, Helena Strömbergsson
1Department of Medical Sciences, Uppsala University, Academic Hospital, SE-751 85, Uppsala, Sweden.
Current Topics in Medicinal Chemistry
|April 8, 2011
Summary
Chemogenomics uses computational methods to model protein-ligand interactions for drug discovery. This review guides proteochemometrics, a quantitative multi-structure-property-relationship modeling approach, for building predictive drug-target models.
Area of Science:
- Interdisciplinary field at the intersection of biology, chemistry, and informatics.
- Focuses on understanding protein-ligand interactions crucial for drug discovery and design.
Background:
- Most drugs are small molecules targeting proteins, making protein-ligand interaction knowledge essential.
- Traditional drug discovery models often focus on specific targets or ligands, limiting scope.
Purpose of the Study:
- To provide a guide to methods and data sources for protein-ligand interaction modeling within chemogenomics.
- To introduce proteochemometrics as a quantitative multi-structure-property-relationship modeling (QMSPR) approach.
- To enable the development of more generalizable models covering broader chemical and biological spaces.
Main Methods:
- Utilizes data matrices containing protein and ligand information with experimental interaction data.
- Employs sophisticated machine learning methods for model induction and validation.
- Covers the entire modeling process: data collection, descriptor computation, preprocessing, induction, and validation.
Main Results:
- Proteochemometrics allows exploitation of sparse/incomplete data sources.
- Enables the creation of models that generalize better across diverse protein-ligand combinations.
- Highlights the importance of interpretable and generalizable models in drug discovery.
Conclusions:
- This review offers a comprehensive overview of data-driven modeling for protein-ligand interactions.
- Addresses challenges and considerations specific to each step of the QMSPR modeling process.
- Emphasizes the potential of chemogenomics and proteochemometrics to advance drug discovery.
Related Concept Videos
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium: